Imperial College London


Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Research Postgraduate







Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus





Rohma Ghani is a Clinical Research Fellow in the Division of Integrative Systems Medicine and Digestive Disease at Imperial College London. She is also an Honorary Specialty Registrar in Infectious Diseases and Microbiology at Imperial College Healthcare NHS Trust.  She is currently studying for a PhD at Imperial College (funded by the NIHR Imperial Biomedical Research Centre (BRC)). 

She is interested in antimicrobial resistance (AMR) and the role of the microbiome and faecal microbiota transplantation (FMT) in patients colonised with multidrug-resistant organisms who are at higher risk from invasive disease and sepsis. 

Selected Publications

Journal Articles

Ghani R, Mullish BH, McDonald JAK, et al., 2021, Disease prevention not decolonization – a model for fecal microbiota transplantation in patients colonized with multidrug-resistant organisms, Clinical Infectious Diseases, Vol:72, ISSN:1058-4838, Pages:1444-1447

Ghani R, Mullish BH, Mcdonald J, et al., 2020, Cohort study of Faecal Microbiota Transplantation for patient’s colonised with MDROs - successful prevention of invasive disease despite low decolonisation rates, Access Microbiology, Vol:2

Ghani R, Gan C, Mullish B, et al., 2019, Prevalence of recurrent extended-spectrum beta-lactamase (ESBL) urinary tract infections (UTIs) in patients within a urology service. Introducing the concept of Faecal Microbiota transplantation (FMT) as a treatment modality., Journal of Clinical Urology

Mullish BH, Ghani R, McDonald J, et al., 2019, Faecal microbiota transplant for eradication of multidrug-resistant Enterobacteriaceae: a lesson in applying best practice? Re: 'A five-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: A Randomized Clinical Trial', Clinical Microbiology and Infection, Vol:25, ISSN:1198-743X, Pages:912-913


Ghani R, Mullish BH, 2020, Decision: Considerations for Use of Fecal Microbiota Transplantation in Special Patient Populations, The 6 Ds of Fecal Microbiota Transplantation: A Primer from Decision to Discharge and Beyond, Editor(s): Allegretti, Kassam, Slack Incorporated, ISBN:9781630917500


Innes AJ, Ghani R, Mullish BH, et al., 2020, O105. Faecal microbiota transplant (FMT) can reduce the high NRM associated with multi-drug resistant organism (MDRO) colonisation prior to allogeneic HCT., The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, Springer Nature [academic journals on], Pages:122-122, ISSN:0268-3369

Ghani R, Gan C, Mullish BH, et al., 2019, P13-2 Prevalence of recurrent Extended Spectrum Beta-Lactamase (ESBL) urinary tract infections (UTIs) in patients within a Urology service and introducing the concept of Faecal Microbiota Transplantation (FMT) as a treatment modality, British Association of Urological Surgeons Annual Scientific Meeting, SAGE Publications, Pages:83-85, ISSN:2051-4158

More Publications